Product Information
XELRIA FE 0.4-0.035 MG CHEW TB is a generic product labeled by Xiromed LLC, priced at $0.5316 per EA under NDC 70700030885. Its NADAC has been published 53 times since Oct 1, 2025.
FDA first approved this application on Apr 1, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700030885
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202086FDA Approved
4/1/2015
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for XELRIA FE 0.4-0.035 MG CHEW TB has been published 53 times since Oct 1, 2025, and over the history we have for it it has declined 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5316 per EA |
|---|---|
| All-time high | $0.5505 (Oct 15, 2025) |
| All-time low | $0.4892 (Apr 22, 2026) |
| 52-week high | $0.5505 |
| 52-week low | $0.4892 |
| Median price | $0.5119 |
| Average price | $0.5112 |
| Largest weekly change | -5.8% (Oct 22, 2025) |
| Weeks tracked | 53 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone and ethinyl estradiol and ferrous fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XELRIA FE 0.4-0.035 MG CHEW TB?
The current National Average Drug Acquisition Cost (NADAC) for XELRIA FE 0.4-0.035 MG CHEW TB, manufactured by Xiromed LLC, is $0.5316 per EA (NDC 70700030885), effective Sep 30, 2026.
How has the price of XELRIA FE 0.4-0.035 MG CHEW TB changed over time?
Over the history we have for it, the NADAC for XELRIA FE 0.4-0.035 MG CHEW TB has declined 3.4%. It has been tracked across 53 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for XELRIA FE 0.4-0.035 MG CHEW TB?
Since Oct 1, 2025, the NADAC for XELRIA FE 0.4-0.035 MG CHEW TB has ranged from a low of $0.4892 (Apr 22, 2026) to a high of $0.5505 (Oct 15, 2025), with a median of $0.5119 per EA.
Are there cheaper alternatives to XELRIA FE 0.4-0.035 MG CHEW TB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORET-ESTR-FE 0.4-0.035(21)-75, is $0.5101 per EA — about 4% below XELRIA FE 0.4-0.035 MG CHEW TB.
Who manufactures XELRIA FE 0.4-0.035 MG CHEW TB?
XELRIA FE 0.4-0.035 MG CHEW TB (NDC 70700030885) is labeled by Xiromed LLC, and CMS classifies it as a generic product.